Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NG-nitro-L-arginine protects against hypoxia/hypoglycemia-induced decrease in CA1 presynaptic spikes in rat

S Shibata1, Y Yamamoto, T Tanaka

  • 1Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

European Journal of Pharmacology
|February 6, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ischemia-induced impairment of 2-deoxyglucose uptake and CA1 field potentials in rat hippocampal slices: protection by 5-HT1A receptor agonists and 5-HT2 receptor antagonists.

European journal of pharmacology·1992
Same author

Effect of substance P on circadian rhythms of firing activity and the 2-deoxyglucose uptake in the rat suprachiasmatic nucleus in vitro.

Brain research·1992
Same author

[Ultrastructure of blood-brain barrier in human brain tumors].

No shinkei geka. Neurological surgery·1992
Same author

Neuroprotective effect of protein kinase C inhibitors on oxygen/glucose free-induced decreases in 2-deoxyglucose uptake and CA1 field potentials in rat hippocampal slices.

Brain research·1992
Same author

Assessment of the role of adrenoceptor function in ischemia-induced impairment of 2-deoxyglucose uptake and CA1 field potential in rat hippocampal slices.

European journal of pharmacology·1992
Same author

Effect of muscarinic cholinergic drugs on ischemia-induced decreases in glucose uptake and CA1 field potentials in rat hippocampus slices.

European journal of pharmacology·1992

Nitric oxide (NO) production appears to facilitate presynaptic dysfunction in the hippocampus during oxygen and glucose deprivation. Inhibiting NO synthase with NG-nitro-L-arginine methyl ester protected against this damage.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Physiology

Background:

  • Hypoxia and hypoglycemia can impair neuronal function, particularly in the hippocampus.
  • Nitric oxide (NO) is a signaling molecule implicated in various neurological processes.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) synthase inhibitors in mitigating hypoxia/hypoglycemia-induced presynaptic dysfunction in rat hippocampal CA1 regions.

Main Methods:

  • Rat hippocampal slices were exposed to hypoxia/hypoglycemia.
  • The effects of nitric oxide (NO) synthase inhibitors (e.g., NG-nitro-L-arginine methyl ester) and NO precursors were assessed on CA1 presynaptic fiber spikes.

Main Results:

  • NG-nitro-L-arginine methyl ester attenuated the hypoxia/hypoglycemia-induced decrease in presynaptic fiber spikes in a dose-dependent manner.

Related Experiment Videos

  • NO precursors exacerbated this deficit, while L-arginine co-treatment reduced the protective effect of the inhibitor.

    • Conclusions:

    • Nitric oxide (NO) production appears to play a facilitatory role in hypoxia/hypoglycemia-induced presynaptic dysfunction in the hippocampal CA1 region.
    • Targeting NO pathways may offer a therapeutic strategy for conditions involving ischemic brain injury.